Arca
Skip to content

RAPT Therapeutics, Inc.

5 private offerings reported to the SEC on Form D since 2016, $317.0M sold in all. Biotech, CA.

  • Form D offerings: 5
  • Reported sold: $317.0M
  • Newest: Jan 3, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Jan 3, 2025$150.0M$150.0MRAPT Therapeutics, Inc.Biotech · CANot amended0001673772-25-000001
Jun 3, 2022$50.0M$50.0MRAPT Therapeutics, Inc.Biotech · CANot amended0001673772-22-000001
Jan 2, 2019$37.1M$67.1MFLX Bio, Inc.Biotech · CAJun 20, 20190001673772-19-000001
Jan 4, 2018$29.9M$59.9MFLX Bio, Inc.Biotech · CANot amended0001673772-18-000001
May 5, 2016$50.0M$50.0MFLX Bio, Inc.Biotech · CANot amended0001673772-16-000001

SEC Profile

From the company's EDGAR record
Business address
South San Francisco, Ca
Incorporated in
DE
SEC industry
Pharmaceutical Preparations
Former names
RAPT Therapeutics, Inc.; FLX Bio, Inc.
All SEC filings
CIK 1673772 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.